| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activated protein C
|
GRIFFIN, J. H.
|
|
2007
|
5 |
s1 |
p. 73-80
|
artikel
|
| 2 |
Approach to the diagnosis and management of mild bleeding disorders
|
GREAVES, M.
|
|
2007
|
5 |
s1 |
p. 167-174
|
artikel
|
| 3 |
Cancer and thrombosis: from molecular mechanisms to clinical presentations
|
BULLER, H. R.
|
|
2007
|
5 |
s1 |
p. 246-254
|
artikel
|
| 4 |
Cell–matrix adhesion in vascular development
|
HYNES, R. O.
|
|
2007
|
5 |
s1 |
p. 32-40
|
artikel
|
| 5 |
Combined antiplatelet and anticoagulant therapy: clinical benefits and risks
|
EIKELBOOM, J. W.
|
|
2007
|
5 |
s1 |
p. 255-263
|
artikel
|
| 6 |
Distal DVT: worth diagnosing? Yes
|
SCHELLONG, S. M.
|
|
2007
|
5 |
s1 |
p. 51-54
|
artikel
|
| 7 |
Drug-eluting stents: trading restenosis for thrombosis?
|
VAN BELLE, E.
|
|
2007
|
5 |
s1 |
p. 238-245
|
artikel
|
| 8 |
Exosites in the substrate specificity of blood coagulation reactions
|
BOCK, P. E.
|
|
2007
|
5 |
s1 |
p. 81-94
|
artikel
|
| 9 |
Factor Xa or thrombin: is factor Xa a better target?
|
ANSELL, J.
|
|
2007
|
5 |
s1 |
p. 60-64
|
artikel
|
| 10 |
Factor Xa or thrombin: Is thrombin a better target?
|
WEITZ, J. I.
|
|
2007
|
5 |
s1 |
p. 65-67
|
artikel
|
| 11 |
Fibrin and fibrinolysis in infection and host defense
|
DEGEN, J. L.
|
|
2007
|
5 |
s1 |
p. 24-31
|
artikel
|
| 12 |
Fibrinolysis, inflammation, and regulation of the plasminogen activating system
|
MEDCALF, R. L.
|
|
2007
|
5 |
s1 |
p. 132-142
|
artikel
|
| 13 |
From hematopoietic stem cells to platelets
|
CHANG, Y.
|
|
2007
|
5 |
s1 |
p. 318-327
|
artikel
|
| 14 |
How to estimate bleeding risk in mild bleeding disorders
|
RODEGHIERO, F.
|
|
2007
|
5 |
s1 |
p. 157-166
|
artikel
|
| 15 |
Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders
|
NEWMAN, P. J.
|
|
2007
|
5 |
s1 |
p. 305-309
|
artikel
|
| 16 |
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach
|
DIMICHELE, D.
|
|
2007
|
5 |
s1 |
p. 143-150
|
artikel
|
| 17 |
Integrated strategies for the diagnosis of venous thromboembolism
|
WELLS, P. S.
|
|
2007
|
5 |
s1 |
p. 41-50
|
artikel
|
| 18 |
In vivo thrombus formation
|
FURIE, B.
|
|
2007
|
5 |
s1 |
p. 12-17
|
artikel
|
| 19 |
Is it worth diagnosing and treating distal deep vein thrombosis? No
|
RIGHINI, M.
|
|
2007
|
5 |
s1 |
p. 55-59
|
artikel
|
| 20 |
Mechanics of proplatelet elaboration
|
ITALIANO, J. E.
|
|
2007
|
5 |
s1 |
p. 18-23
|
artikel
|
| 21 |
Menorrhagia associated with laboratory abnormalities of hemostasis: epidemiological, diagnostic and therapeutic aspects
|
KOUIDES, P. A.
|
|
2007
|
5 |
s1 |
p. 175-182
|
artikel
|
| 22 |
Molecular mechanisms accounting for fibrinogen deficiency: from large deletions to intracellular retention of misfolded proteins
|
VU, D.
|
|
2007
|
5 |
s1 |
p. 125-131
|
artikel
|
| 23 |
Past and future of genetic research in thrombosis
|
REITSMA, P. H.
|
|
2007
|
5 |
s1 |
p. 264-269
|
artikel
|
| 24 |
Phenotypic heterogeneity in severe hemophilia
|
VAN DEN BERG, H. M.
|
|
2007
|
5 |
s1 |
p. 151-156
|
artikel
|
| 25 |
Plaque progression and regression in atherothrombosis
|
IBANEZ, B.
|
|
2007
|
5 |
s1 |
p. 292-299
|
artikel
|
| 26 |
Platelet genomics and the risk of atherothrombosis
|
OUWEHAND, W. H.
|
|
2007
|
5 |
s1 |
p. 188-195
|
artikel
|
| 27 |
Platelet receptor recognition and cross-talk in collagen-induced activation of platelets
|
FARNDALE, R. W.
|
|
2007
|
5 |
s1 |
p. 220-229
|
artikel
|
| 28 |
Platelets, inflammation and atherosclerosis
|
LINDEMANN, S.
|
|
2007
|
5 |
s1 |
p. 203-211
|
artikel
|
| 29 |
Preface
|
de Moerloose, Philippe
|
|
2007
|
5 |
s1 |
p. i
|
artikel
|
| 30 |
Programmed autologous cleavage of platelet receptors
|
BERNDT, M. C.
|
|
2007
|
5 |
s1 |
p. 212-219
|
artikel
|
| 31 |
Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection
|
CATTANEO, M.
|
|
2007
|
5 |
s1 |
p. 230-237
|
artikel
|
| 32 |
Serpins in thrombosis, hemostasis and fibrinolysis
|
RAU, J. C.
|
|
2007
|
5 |
s1 |
p. 102-115
|
artikel
|
| 33 |
Structure of fibrin: impact on clot stability
|
WEISEL, J. W.
|
|
2007
|
5 |
s1 |
p. 116-124
|
artikel
|
| 34 |
SUBJECT INDEX
|
|
|
2007
|
5 |
s1 |
p. 329-331
|
artikel
|
| 35 |
The central role of thrombin in hemostasis
|
CRAWLEY, J. T. B.
|
|
2007
|
5 |
s1 |
p. 95-101
|
artikel
|
| 36 |
Thrombin as procoagulant and anticoagulant
|
CERA, E. DI
|
|
2007
|
5 |
s1 |
p. 196-202
|
artikel
|
| 37 |
Thrombophilia and pregnancy complications: cause or association?
|
MIDDELDORP, S.
|
|
2007
|
5 |
s1 |
p. 276-282
|
artikel
|
| 38 |
Thrombosis and bleeding disorders outside Western countries
|
MANNUCCI, P. M.
|
|
2007
|
5 |
s1 |
p. 68-72
|
artikel
|
| 39 |
Type 1 von Willebrand disease
|
PEAKE, I.
|
|
2007
|
5 |
s1 |
p. 7-11
|
artikel
|
| 40 |
Vascular bed-specific thrombosis
|
AIRD, W. C.
|
|
2007
|
5 |
s1 |
p. 283-291
|
artikel
|
| 41 |
Vascular proteomic mapping in vivo
|
SIMONSON, A. B.
|
|
2007
|
5 |
s1 |
p. 183-187
|
artikel
|
| 42 |
Venous thromboembolism and atherosclerosis: is there a link?
|
PRANDONI, P.
|
|
2007
|
5 |
s1 |
p. 270-275
|
artikel
|
| 43 |
Venous thrombosis in the elderly
|
ROSENDAAL, F. R.
|
|
2007
|
5 |
s1 |
p. 310-317
|
artikel
|
| 44 |
VKORC1: molecular target of coumarins
|
OLDENBURG, J.
|
|
2007
|
5 |
s1 |
p. 1-6
|
artikel
|
| 45 |
Zebrafish: from hematology to hydrology
|
JAGADEESWARAN, P.
|
|
2007
|
5 |
s1 |
p. 300-304
|
artikel
|
Tijdschrift beschrijving